Investments S.A.R.L.Rusnano... Net Worth

The estimated Net Worth of Investments S.A.R.L.Rusnano... is at least $2.04 Milion dollars as of 7 June 2016. Investments Rusnano owns over 42,857 units of Clearside Biomedical Inc stock worth over $2,041,011 and over the last 8 years Investments sold CLSD stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Investments Rusnano CLSD stock SEC Form 4 insiders trading

Investments has made over 2 trades of the Clearside Biomedical Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Investments bought 42,857 units of CLSD stock worth $299,999 on 7 June 2016.

The largest trade Investments's ever made was buying 42,857 units of Clearside Biomedical Inc stock on 7 June 2016 worth over $299,999. On average, Investments trades about 42,857 units every 0 days since 2016. As of 7 June 2016 Investments still owns at least 1,558,024 units of Clearside Biomedical Inc stock.

You can see the complete history of Investments Rusnano stock trades at the bottom of the page.

What's Investments Rusnano's mailing address?

Investments's mailing address filed with the SEC is 7, ROBERT STUMPER44, BLDG. 1, KRASNOBOGATYRSKAYA STREET, , GRAND DUCHYMOSCOW, N41Z, L-2557107076.

Insiders trading at Clearside Biomedical Inc

Over the last 8 years, insiders at Clearside Biomedical Inc have traded over $11,999,807 worth of Clearside Biomedical Inc stock and bought 4,477,928 units worth $22,264,136 . The most active insiders traders include Bradford T Whitmore, Clay Thorp oraz Venture Advisors Iv Sbic, L.... On average, Clearside Biomedical Inc executives and independent directors trade stock every 30 days with the average trade being worth of $82,593. The most recent stock trade was executed by Ngai Hang Victor Chong on 24 June 2024, trading 23,500 units of CLSD stock currently worth $24,910.

What does Clearside Biomedical Inc do?

clearside biomedical, inc. is a pharmaceuticals company located in 1220 old alpharetta rd., suite 300, alpharetta, ga, united states.

Complete history of Investments Rusnano stock trades at Clearside Biomedical Inc

Clearside Biomedical Inc executives and stock owners

Clearside Biomedical Inc executives and other stock owners filed with the SEC include:

• George Lasezkay,
  President, Chief Executive Officer, Director
• Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.,
  Pres, CEO & Director
• Dr. George M. Lasezkay Pharm.D., Pharma.D., J.D.,
  Pres, CEO & Director
• Charles Deignan,
  Chief Financial Officer
• Dr. Thomas A. Ciulla M.B.A., M.D.,
  Chief Medical Officer & Chief Devel. Officer
• Charles A. Deignan,
  Chief Financial Officer
• Jenny Kobin,
  IR Contact Officer
• Clay Thorp,
  Independent Director
• Nancy Hutson,
  Independent Director
• William Humphries,
  Independent Director
• Jeffrey Edwards,
  Independent Director
• Richard Croarkin,
  Independent Director
• Christy Shaffer,
  Independent Chairman of the Board
• Susan L. Coultas Ph.D.,
  Chief Clinical Officer
• Rick McElheny,
  VP of Corp. Devel.
• Leslie B. Zacks,
  Gen. Counsel, Chief Compliance Officer & Sec.
• Jenny R. Kobin,
  Head of Investor Relations
• Venture Advisors Iii, Llc H...,
  
• Venture Advisors Iv Sbic, L...,
  
• Venture Advisors Iii, Llc H...,
  
• Evgeny Zaytsev,
  Director
• Daniel H. White,
  President and CEO
• Investments S.A.R.L.Rusnano...,
  
• Derek Yoon,
  Director
• Gerald D. Cagle,
  Director
• Venture Advisors Iv Sbic, L...,
  
• Glenn Noronha,
  Executive Vice President, R&D
• Thomas Ciulla,
  Chief Medical Officer
• Brion S. Raymond,
  Chief Commercial Officer
• Anthony S Gibney,
  
• Bradford T Whitmore,
  10% owner
• Ngai Hang Victor Chong,
  Chief Medical Officer
• Benjamin R Yerxa,